Abstract：Cancer is the second leading cause of mortality worldwide, and a quarter of global cancerrelated deaths occur in China. At present, cardiovascular disease has emerged as the second most common cause of death among cancer survivors subsequent to cancer recurrence and metastasis. Accurate prediction and early diagnosis of potential cardiovascular toxicity during cancer treatment could not only optimize patients clinical outcomes but also could alleviate the burden on the healthcare system. This article provides a comprehensive overview of recent research pertaining to predicting and early diagnosing cancer therapyrelated cardiovascular toxicity, offering valuable insights into identifying highrisk patients.
彭佳，白芳，林燕青，罗安果，尹立雪. 肿瘤治疗相关心血管毒性预测及早期诊断的研究进展[J]. 实用心电学杂志, 2024, 33(2): 166-174.
彭佳，白芳，林燕青，罗安果，尹立雪. Progress of prediction and early diagnosis of cancer therapyrelated cardiovascular toxicity. JOURNAL OF PRACTICAL ELECTROCARDIOLOGY, 2024, 33(2): 166-174.
